These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24350939)

  • 1. [The position of tiotropium in new treatment guidelines for chronic obstructive pulmonary disease].
    Koblížek V
    Vnitr Lek; 2013 Dec; 59(12):1073-80. PubMed ID: 24350939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
    Ma J; Zhou Z; Tang Y; Zhong N
    Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Kasak V
    Vnitr Lek; 2013 Dec; 59(12):1041-2. PubMed ID: 24466606
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current position of new fixed-dose combination of tiotropium and olodaterol - its role in the treatment of chronic obstructive pulmonary disease in the Czech Republic].
    Koblížek V; Svoboda M
    Vnitr Lek; 2016; 62(12):1011-1020. PubMed ID: 28139131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.
    Miravitlles M; Urrutia G; Mathioudakis AG; Ancochea J
    Respir Res; 2017 Nov; 18(1):196. PubMed ID: 29178871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials.
    Singh S; Loke YK; Enright PL; Furberg CD
    BMJ; 2011 Jun; 342():d3215. PubMed ID: 21672999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials.
    Dong YH; Lin HH; Shau WY; Wu YC; Chang CH; Lai MS
    Thorax; 2013 Jan; 68(1):48-56. PubMed ID: 23042705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium.
    O'Connor AB
    Ann Intern Med; 2006 Jan; 144(2):148; author reply 148-9. PubMed ID: 16418423
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium.
    Good CB; Longo L
    Ann Intern Med; 2006 Jan; 144(2):147; author reply 148-9. PubMed ID: 16418422
    [No Abstract]   [Full Text] [Related]  

  • 14. [Spiolto Respimat® : tiotropium-olodaterol fixed combination for therapy of chronic obstructive pulmonary disease (COPD)].
    Cataldo D
    Rev Med Liege; 2016 Jun; 71(6):308-313. PubMed ID: 28383865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
    Vestbo J; Papi A; Corradi M; Blazhko V; Montagna I; Francisco C; Cohuet G; Vezzoli S; Scuri M; Singh D
    Lancet; 2017 May; 389(10082):1919-1929. PubMed ID: 28385353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.
    Trudo F; Kern DM; Davis JR; Tunceli O; Zhou S; Graham EL; Strange C; Williams SA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2055-66. PubMed ID: 26451101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?
    Dahl R; Kaplan A
    BMC Pulm Med; 2016 Oct; 16(1):135. PubMed ID: 27724909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.
    Ismaila AS; Huisman EL; Punekar YS; Karabis A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2495-517. PubMed ID: 26604738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summaries for patients. Tiotropium and the treatment of chronic obstructive lung disease.
    Ann Intern Med; 2005 Sep; 143(5):I20. PubMed ID: 16144886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.